直接青霉素激发试验的反应风险:系统评价与Meta分析
该研究系统检索MEDLINE、Web of Science和Scopus(建库至2023年7月19日),纳入56项原始研究共9225例有青霉素过敏标签并接受直接青霉素激发试验的患者,采用随机效应贝叶斯比例Meta分析。结果显示438例发生反应,总体频率3.5%(95%CrI 2.5%-4.6%);北美研究反应率较低(OR 0.36,95%CrI 0.20-0.61),儿童(OR 3.37,95%CrI 1.98-5.98)、门诊患者(OR 2.19,95%CrI 1.08-4.75)、分级激发(OR 3.24,95%CrI 1.50-7.06)和延长激发(OR 5.45,95%CrI 2.38-13.28)与较高反应率相关。仅报告5例严重反应(3例过敏性休克、1例发热伴皮疹、1例急性肾损伤),无致死性反应。作者认为直接激发试验的反应频率与过敏测试后间接激发试验相当,可安全纳入青霉素过敏评估工作。
要点
- 9225例有青霉素过敏标签者直接激发后438例发生反应,总体反应频率3.5%(95%CrI 2.5%-4.6%)。
- 仅报告5例严重反应(3例过敏性休克、1例发热伴皮疹、1例急性肾损伤),无致死性反应。
- 儿童(OR 3.37,95%CrI 1.98-5.98)、门诊(OR 2.19,95%CrI 1.08-4.75)、分级激发(OR 3.24,95%CrI 1.50-7.06)和延长激发(OR 5.45,95%CrI 2.38-13.28)的反应率更高。
- 北美开展的研究反应率较低(OR 0.36,95%CrI 0.20-0.61)。
- 作者认为直接激发试验的反应频率与过敏测试后间接激发试验相当,可安全纳入青霉素过敏评估工作。
适用人群与场景
- 有青霉素过敏标签并接受直接青霉素激发试验的个体,涵盖各年龄组和临床场景(研究纳入门诊和儿童等人群)。
- 系统评价纳入原始研究不限制发表年份、语言、状态或过敏风险定义。
研究设计与关键结果
- 系统评价与Meta分析纳入56项原始研究、共9225例参与者;438例在无先前测试情况下直接青霉素激发后发生反应,总体Meta分析频率3.5%(95%CrI 2.5%-4.6%)。
- Meta回归显示北美研究反应率较低(OR 0.36,95%CrI 0.20-0.61);儿童(OR 3.37,95%CrI 1.98-5.98)、门诊患者(OR 2.19,95%CrI 1.08-4.75)、分级激发(OR 3.24,95%CrI 1.50-7.06)和延长激发(OR 5.45,95%CrI 2.38-13.28)反应率更高。
- 仅报告5例严重反应:3例过敏性休克、1例发热伴皮疹、1例急性肾损伤,均无致死性。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(随机效应贝叶斯比例Meta分析),纳入56项原始研究共9225例参与者。
- 采用偏倚风险工具独立评估每项原始研究的质量。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,直接青霉素激发试验的反应频率与过敏测试后间接激发试验相当,可安全纳入各年龄段和临床场景的青霉素过敏评估工作。
- 儿童、门诊患者以及采用分级或延长激发方案时反应率更高,北美以外地区研究反应率也更高(北美OR 0.36,95%CrI 0.20-0.61)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: While direct penicillin challenges might support the expansion of penicillin allergy delabeling efforts, the perceived risk of reactions remains a key barrier.
OBJECTIVE: To evaluate the frequency of reactions to direct penicillin challenges in individuals with penicillin allergy labels and to identify factors associated with such reactions.
DATA SOURCES: Three electronic databases were searched (MEDLINE, Web of Science, and Scopus) from inception to July 19, 2023, for primary studies assessing patients undergoing direct penicillin challenges. Articles were included regardless of publication year, language, status, or definition of allergy risk.
STUDY SELECTION: Two reviewers independently selected original studies reporting the frequency of immunologically mediated reactions following a direct penicillin challenge in patients reporting a penicillin allergy.
DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and independently assessed the quality of each primary study using a risk-of-bias tool for prevalence studies.
MAIN OUTCOMES AND MEASURES: The primary outcome was the frequency of reactions to direct penicillin challenges as calculated using random-effects bayesian meta-analysis of proportions. Secondary outcomes included risk factors for reactions and the frequency of severe reactions.
RESULTS: A total of 56 primary studies involving 9225 participants were included. Among participants, 438 experienced reactions to direct penicillin challenges without prior testing, corresponding to an overall meta-analytic frequency of 3.5% (95% credible interval [CrI], 2.5%-4.6%). Meta-regression analyses revealed that studies performed in North America had lower rates of reaction to direct challenges (odds ratio [OR], 0.36; 95% CrI, 0.20-0.61), while studies performed in children (OR, 3.37; 95% CrI, 1.98-5.98), in outpatients (OR, 2.19; 95% CrI, 1.08-4.75), and with a graded (OR, 3.24; 95% CrI, 1.50-7.06) or prolonged (OR, 5.45; 95% CrI, 2.38-13.28) challenge had higher rates of reaction. Only 5 severe reactions (3 anaphylaxis, 1 fever with rash, and 1 acute kidney injury) were reported, none of which were fatal.
CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found that reactions to direct penicillin challenges are infrequent, with rates comparable to indirect challenges after allergy testing. These findings suggest that direct challenges are safe for incorporation into penicillin allergy evaluation efforts across age groups and clinical settings.
参考来源
- Blumenthal KG, Smith LR, Mann JTS, et al. Reaction Risk to Direct Penicillin Challenges: A Systematic Review and Meta-Analysis. JAMA Intern Med. 2024. PMID: 39283610. doi:10.1001/jamainternmed.2024.4606
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。